Patents by Inventor Giulia Grisendi

Giulia Grisendi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210300990
    Abstract: Method for the production of bi-functional cells comprising engineering a starting cell population with a phenotype attributable to human pericytes extracted from adipose tissue (AD-PC), obtaining engineered cells, known as bi-functional AD-PCs, expressing (which means that they produce) simultaneously both the anti-tumor molecule TRAIL and also the truncated form of a chimeric receptor targeted against the GD2 antigen (GD2 tCAR); this dual targeting (understood as reaching a specific target), based on affinity and mediated by both TRAIL and also GD2 tCAR, supports the prediction of combining site-specificity with a prolonged retention of AD-PCs in tumors expressing the antigen GD2, so as to achieve a more effective release of TRAIL for still incurable tumors.
    Type: Application
    Filed: July 30, 2019
    Publication date: September 30, 2021
    Inventors: Giulia Golinelli, Giulia Grisendi, Carlotta Spano, Olivia Candini, Massimo Dominici
  • Publication number: 20210214689
    Abstract: The method to produce conditionally apoptotic cells comprises modifying a cell population with a phenotype attributable to human adipose tissue-derived pericytes (AD-PC) expressing anti-tumor TRAIL introducing a sequence coding a conditional suicide gene (CSG).
    Type: Application
    Filed: May 31, 2019
    Publication date: July 15, 2021
    Inventors: Filippo Rossignoli, Carlotta Spano, Giulia Grisendi, Olivia Candini, Massimo Dominici
  • Publication number: 20210054339
    Abstract: Method for the production of cellular particulate with antitumor activity, which comprises isolating the cellular particulate originating from a cell population with a phenotype that can be attributed to human adipose tissue derived pericytes (AD-PC) that express antitumor TRAIL.
    Type: Application
    Filed: April 24, 2019
    Publication date: February 25, 2021
    Inventors: Filippo Rossignoli, Carlotta Spano, Giulia Grisendi, Olivia Candini, Massimo Dominici
  • Patent number: 9572838
    Abstract: A method for production of anti-tumor TRAIL includes inserting a TRAIL molecule, encoded by a viral vector irreversibly derived from a cell line, into a carrier cell, thereby obtaining a stably TRAIL-producing carrier cell, and wherein the TRAIL molecule includes a soluble molecule.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: February 21, 2017
    Inventors: Massimo Dominici, Rita Bussolari, Giulia Grisendi, Pierfranco Conte
  • Publication number: 20150320803
    Abstract: A method for production of anti-tumor TRAIL includes inserting a TRAIL molecule, encoded by a viral vector irreversibly derived from a cell line, into a carrier cell, thereby obtaining a stably TRAIL-producing carrier cell, and wherein the TRAIL molecule includes a soluble molecule.
    Type: Application
    Filed: March 13, 2015
    Publication date: November 12, 2015
    Inventors: Massimo Dominici, Rita Bussolari, Giulia Grisendi, Pierfranco Conte
  • Publication number: 20120100614
    Abstract: The method for production of anti-tumor TRAIL comprises: inserting a TRAIL molecule, encoded by a viral vector irreversibly derived from a cell line, into a carrier cell, thereby obtaining a stably TRAIL-producing carrier cell, said TRAIL molecule comprising a soluble molecule.
    Type: Application
    Filed: April 28, 2010
    Publication date: April 26, 2012
    Inventors: Massimo Dominici, Rita Bussolari, Giulia Grisendi, Pierfranco Conte